# Independent Bank Corp: financial statements, quarterly

IBCP · Nasdaq · CIK 39311 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ibcp.md) · [Financials](/companies/ibcp/financials.md) · [Filings](/companies/ibcp/filings.md) · [Insiders](/companies/ibcp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ibcp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [9.1](/filings/0000039311-24-000090.md) | [8.2 d](/filings/0000039311-26-000009.md) | [7.6](/filings/0000039311-25-000065.md) | [7.9](/filings/0000039311-25-000093.md) | [8.8](/filings/0000039311-25-000101.md) | [7.7 d](/filings/0000039311-26-000009.md) | [7.3](/filings/0000039311-26-000048.md) | [7.9](/filings/0000039311-26-000061.md) | [8.9](/filings/0000039311-25-000101.md) | [7.9 d](/filings/0000039311-26-000009.md) | [7.6](/filings/0000039311-26-000048.md) | [8.2](/filings/0000039311-26-000061.md) |
| Interest expense | $m | [23.0](/filings/0000039311-23-000091.md) | [25.3 d](/filings/0000039311-24-000035.md) | [24.9](/filings/0000039311-24-000056.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.1](/filings/0000039311-24-000090.md) | [4.2 d](/filings/0000039311-26-000009.md) | [3.8](/filings/0000039311-25-000065.md) | [4.6](/filings/0000039311-25-000093.md) | [3.5](/filings/0000039311-25-000101.md) | [4.3 d](/filings/0000039311-26-000009.md) | [3.5](/filings/0000039311-26-000048.md) | [3.8](/filings/0000039311-26-000061.md) | [3.7](/filings/0000039311-25-000101.md) | [1.7 d](/filings/0000039311-26-000009.md) | [3.4](/filings/0000039311-26-000048.md) | [3.9](/filings/0000039311-26-000061.md) |
| Net income | $m | [17.5](/filings/0000039311-24-000090.md) | [13.7 d](/filings/0000039311-26-000009.md) | [16.0](/filings/0000039311-26-000009.md) | [18.5](/filings/0000039311-26-000009.md) | [13.8](/filings/0000039311-26-000009.md) | [18.5](/filings/0000039311-26-000009.md) | [15.6](/filings/0000039311-26-000048.md) | [16.9](/filings/0000039311-26-000061.md) | [17.5](/filings/0000039311-26-000009.md) | [18.6](/filings/0000039311-26-000009.md) | [16.9](/filings/0000039311-26-000048.md) | [18.8](/filings/0000039311-26-000061.md) |
| Diluted EPS | $ per share | [0.83](/filings/0000039311-24-000090.md) | not reported | [0.76](/filings/0000039311-26-000009.md) | [0.88](/filings/0000039311-26-000009.md) | [0.65](/filings/0000039311-26-000009.md) | [0.87](/filings/0000039311-26-000009.md) | [0.74](/filings/0000039311-26-000048.md) | [0.81](/filings/0000039311-26-000061.md) | [0.84](/filings/0000039311-26-000009.md) | [0.89](/filings/0000039311-26-000009.md) | [0.81](/filings/0000039311-26-000048.md) | [0.90](/filings/0000039311-26-000061.md) |
| Basic EPS | $ per share | [0.84](/filings/0000039311-24-000090.md) | not reported | [0.77](/filings/0000039311-26-000009.md) | [0.89](/filings/0000039311-26-000009.md) | [0.66](/filings/0000039311-26-000009.md) | [0.88](/filings/0000039311-26-000009.md) | [0.74](/filings/0000039311-26-000048.md) | [0.81](/filings/0000039311-26-000061.md) | [0.85](/filings/0000039311-26-000009.md) | [0.90](/filings/0000039311-26-000009.md) | [0.82](/filings/0000039311-26-000048.md) | [0.91](/filings/0000039311-26-000061.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [127](/filings/0000039311-23-000091.md) | [170](/filings/0000039311-25-000044.md) | [162](/filings/0000039311-24-000056.md) | [214](/filings/0000039311-24-000073.md) | [122](/filings/0000039311-24-000090.md) | [120](/filings/0000039311-26-000009.md) | [128](/filings/0000039311-25-000065.md) | [146](/filings/0000039311-25-000093.md) | [209](/filings/0000039311-25-000101.md) | [138](/filings/0000039311-26-000061.md) | [175](/filings/0000039311-26-000048.md) | [165](/filings/0000039311-26-000061.md) |
| Total assets | $m | [5,200](/filings/0000039311-23-000091.md) | [5,264](/filings/0000039311-26-000009.md) | [5,231](/filings/0000039311-25-000065.md) | [5,278](/filings/0000039311-25-000093.md) | [5,259](/filings/0000039311-25-000101.md) | [5,338](/filings/0000039311-26-000009.md) | [5,328](/filings/0000039311-26-000048.md) | [5,419](/filings/0000039311-26-000061.md) | [5,493](/filings/0000039311-25-000101.md) | [5,506](/filings/0000039311-26-000061.md) | [5,558](/filings/0000039311-26-000048.md) | [5,664](/filings/0000039311-26-000061.md) |
| Total liabilities | $m | [4,825](/filings/0000039311-23-000091.md) | [4,859](/filings/0000039311-25-000044.md) | [4,816](/filings/0000039311-24-000056.md) | [4,847](/filings/0000039311-24-000073.md) | [4,807](/filings/0000039311-24-000090.md) | [4,883](/filings/0000039311-26-000009.md) | [4,861](/filings/0000039311-25-000065.md) | [4,949](/filings/0000039311-25-000093.md) | [5,002](/filings/0000039311-25-000101.md) | [5,003](/filings/0000039311-26-000061.md) | [5,047](/filings/0000039311-26-000048.md) | [5,135](/filings/0000039311-26-000061.md) |
| Shareholders' equity | $m | [375](/filings/0000039311-24-000090.md) | [404](/filings/0000039311-26-000009.md) | [416](/filings/0000039311-25-000093.md) | [430](/filings/0000039311-25-000101.md) | [452](/filings/0000039311-25-000101.md) | [455](/filings/0000039311-26-000061.md) | [467](/filings/0000039311-26-000061.md) | [469](/filings/0000039311-26-000061.md) | [491](/filings/0000039311-25-000101.md) | [503](/filings/0000039311-26-000061.md) | [511](/filings/0000039311-26-000061.md) | [528](/filings/0000039311-26-000061.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.7 d](/filings/0000039311-24-000090.md) | [16.8 d](/filings/0000039311-26-000009.md) | [20.8](/filings/0000039311-25-000065.md) | [8.7 d](/filings/0000039311-25-000093.md) | [17.2 d](/filings/0000039311-25-000101.md) | [16.4 d](/filings/0000039311-26-000009.md) | [19.3](/filings/0000039311-26-000048.md) | [19.2 d](/filings/0000039311-26-000061.md) | [30.4 d](/filings/0000039311-25-000101.md) | [7.8 d](/filings/0000039311-26-000009.md) | [(9.2)](/filings/0000039311-26-000048.md) | [20.3 d](/filings/0000039311-26-000061.md) |
| Capital expenditure | $m | [1.4 d](/filings/0000039311-24-000090.md) | [1.5 d](/filings/0000039311-26-000009.md) | [0.7](/filings/0000039311-25-000065.md) | [1.8 d](/filings/0000039311-25-000093.md) | [1.5 d](/filings/0000039311-25-000101.md) | [4.0 d](/filings/0000039311-26-000009.md) | [1.1](/filings/0000039311-26-000048.md) | [2.3 d](/filings/0000039311-26-000061.md) | [1.7 d](/filings/0000039311-25-000101.md) | [1.4 d](/filings/0000039311-26-000009.md) | [4.6](/filings/0000039311-26-000048.md) | [3.6 d](/filings/0000039311-26-000061.md) |
| Dividends paid | $m | [4.8 d](/filings/0000039311-24-000090.md) | [4.8 d](/filings/0000039311-26-000009.md) | [5.0](/filings/0000039311-25-000065.md) | [5.0 d](/filings/0000039311-25-000093.md) | [5.0 d](/filings/0000039311-25-000101.md) | [5.0 d](/filings/0000039311-26-000009.md) | [5.4](/filings/0000039311-26-000048.md) | [5.4 d](/filings/0000039311-26-000061.md) | [5.4 d](/filings/0000039311-25-000101.md) | [5.4 d](/filings/0000039311-26-000009.md) | [5.8](/filings/0000039311-26-000048.md) | [5.8 d](/filings/0000039311-26-000061.md) |
| Share repurchases | $m | [1.7 d](/filings/0000039311-24-000090.md) | [0.2 d](/filings/0000039311-26-000009.md) | [0.0](/filings/0000039311-25-000065.md) | [0.0 d](/filings/0000039311-25-000093.md) | [0.0 d](/filings/0000039311-25-000101.md) | [0.0 d](/filings/0000039311-26-000009.md) | [0.0](/filings/0000039311-26-000048.md) | [7.3 d](/filings/0000039311-26-000061.md) | [0.4 d](/filings/0000039311-25-000101.md) | [4.7 d](/filings/0000039311-26-000009.md) | [0.0](/filings/0000039311-26-000048.md) | [0.0 d](/filings/0000039311-26-000061.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.2](/filings/0000039311-26-000048.md) | [20.9](/filings/0000039311-26-000061.md) | [20.8](/filings/0000039311-26-000048.md) | [20.8](/filings/0000039311-26-000061.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,199,295 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0000039311-26-000061.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.